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Abstract
Background: Exosomes consist of membrane vesicles that are secreted by several cell types, including tumors and
have been found in biological fluids. Exosomes interact with other cells and may serve as vehicles for the transfer
of protein and RNA among cells.
Methods: SKOV3 exosomes were labelled with carboxyfluoresceine diacetate succinimidyl-ester and collected by
ultracentrifugation. Uptake of these vesicles, under different conditions, by the same cells from where they
originated was monitored by immunofluorescence microscopy and flow cytometry analysis. Lectin analysis was
performed to investigate the glycosylation properties of proteins from exosomes and cellular extracts.
Results: In this work, the ovarian carcinoma SKOV3 cell line has been shown to internalize exosomes from the
same cells via several endocytic pathways that were strongly inhibited at 4°C, indicating their energy dependence.
Partial colocalization with the endosome marker EEA1 and inhibition by chlorpromazine suggested the
involvement of clathrin-dependent endocytosis. Furthermore, uptake inhibition in the presence of 5-ethyl-N-
isopropyl amiloride, cytochalasin D and methyl-beta-cyclodextrin suggested the involvement of additional
endocytic pathways. The uptake required proteins from the exosomes and from the cells since it was inhibited
after proteinase K treatments. The exosomes were found to be enriched in specific mannose- and sialic acid-
containing glycoproteins. Sialic acid removal caused a small but non-significant increase in uptake. Furthermore,
the monosaccharides D-galactose, a-L-fucose, a-D-mannose, D-N-acetylglucosamine and the disaccharide b-lactose
reduced exosomes uptake to a comparable extent as the control D-glucose.
Conclusions: In conclusion, exosomes are internalized by ovarian tumor cells via various endocytic pathways and
proteins from exosomes and cells are required for uptake. On the other hand, exosomes are enriched in specific
glycoproteins that may constitute exosome markers. This work contributes to the knowledge about the properties
and dynamics of exosomes in cancer.
Background
Exosomes are small membrane vesicles between 40-100 nm
in diameter that are secreted by various cell types, including
tumor cells, neurons, B- and T- lymphocytes, intestinal
epithelial cells [1-3] and in physiological fluids [3,4].
Exosome biogenesis involves the inward budding of
endosomes into multivesicular bodies to form intralum-
inal vesicles that are then released to the extracellular
space. During this process transmembrane proteins
are incorporated into the invaginating membrane
maintaining the same topological orientation as the
plasma membrane, while cytosolic components are
engulfed.
The molecular basis of protein sorting during exosomes
formation appears to involve a ubiquitin-dependent
mechanism and the endosomal sorting complexes
required for transport (ESCRT) [5,6]. However, some
proteins present in the exosomes are not ubiquitinated
suggesting that other mechanisms such as oligomerization
or partitioning of protein into lipid raft domains may be
involved [6-9].
Exosomes are released by multivesicular bodies fusion
with the plasma membrane and the mechanism appears
to involve Rab27A and Rab27B [10]. Recent studies have
suggested their participation in different physiological
* Correspondence: jcosta@itqb.unl.pt
1Instituto de Tecnologia Química e Biológica, Apartado 127, 2781-901 Oeiras,
Portugal
Full list of author information is available at the end of the article
Escrevente et al. BMC Cancer 2011, 11:108
http://www.biomedcentral.com/1471-2407/11/108
© 2011 Escrevente et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.and/or pathological processes, such as, tumor progres-
sion, stimulation of the immune system, coagulation and
inflammation and intercellular transfer of infectious
agents, such as proteins and RNA [4,6,8].
Many of the functions described for exosomes
depend on their ability to specifically interact with a
target cell and several types of interaction have already
been proposed based on indirect evidence and in vitro
studies. Exosomes can associate with the plasma mem-
brane through ligand-receptor interactions [11] or
lipids, such as phosphatidylserine [12]. The process of
internalization can occur through direct fusion of the
exosomes with the plasma membrane, leading to the
release of the exosomal content into the cell cyto-
plasm. Alternatively, exosomes can enter the cells by
receptor-mediated endocytosis and later fuse with the
limiting membrane of the endosome releasing the exo-
somal content to be recycled to the cell surface or to
be degraded in the lysosome [11,13]. Exosome uptake
was shown to occur via clathrin-mediated endocytosis
in dendritic cells [14], as well as phagocytosis in
monocytes and macrophages [15].
Exosomes have a unique protein and lipid composi-
tion that varies depending on the cells from which they
originate, nevertheless, as a consequence of their endo-
somal origin nearly all exosomes contain proteins
involved in membrane transport and fusion (RabGT-
Pases, annexins, flotilin), in multivesicular bodies
biogenesis (TSG101, Alix), heat shock proteins (Hsc70,
Hsc90), integrins and tetraspanins (CD9, CD63, CD81,
CD82) [16,17]. In addition, they are enriched in raft-
lipids such as cholesterol, sphingolipids and ceramide.
In exosomes, an enrichment of certain glycosylated
motifs has also been observed [18].
Glycosylation is a post-translational modification that
plays an important role in several properties of proteins
including stability, folding, intracellular trafficking and
recognition. Lectins and their interactions with carbohy-
drates have been found to play a role in exosome uptake
by dendritic cells [19] and macrophages [20].
In the present work, the SKOV3 ovarian carcinoma
cell line has been shown to internalize exosomes derived
from the same cells via various endocytic pathways. Pro-
teins from exosomes and from cells were required for
the uptake. On the other hand, exosomes were highly
enriched in specific glycosylated sialic acid- and man-
nose-containing glycoproteins, and sialic acid removal




Human ovarian cancer SKOV3, embryonic kidney
HEK293 and neuroglioma H4 cell lines were grown in
Dulbecco’s Modified Eagle Medium (DMEM) (Sigma) at
37°C, 5% CO2 supplemented with 10% fetal calf serum
(Gibco), 1% penicillin/streptomycin solution (Gibco).
Isolation of secreted membrane vesicles
Confluent SKOV3, HEK293 and H4 cells were cultivated
for 24 h in serum-free medium. The supernatant was col-
lected and centrifuged, at 500, 10,000 and 100,000 × g 10,
20 and 120 min, respectively, at 4°C. The pellet of the last
centrifugation consisted of secreted membrane vesicles.
Sucrose-density-fractionation was performed as
described previously [21].
Glycoprotein detection using lectins and immunoblot
Cellular extracts were obtained by solubilization of cen-
trifuged cells in Triton X-100 buffer (50 mM Tris-HCl
pH 7.5, 5 mM EDTA, 1% Triton X-100, 0.02% protease
inhibitors cocktail, Complete, Roche), for 30 min. Total
protein concentration was determined by the bicincho-
ninic acid (BCA) method.
Glycoproteins from total cellular extracts and secreted
membrane vesicles were stained after transfer to polyvi-
nylidene difluoride (PVDF) membrane with lectins. Con-
canavalin A (Con A) (Sigma), biotinylated Sambucus
nigra (SNA) and Maackia amurensis lectin (MAL)
(Galab Technologies) were used. Glycoproteins were
fixed on the PVDF membrane with 25% (v/v) 2-propa-
nol and 10% (v/v) acetic acid for 5 min. The membranes
were blocked for 1 h with TBS, 0.1% Tween-20 (TTBS)
for Con A or with TTBS containing 2% BSA for SNA
and MAL. For Con A detection the membrane was
incubated overnight with 25 μg/ml Con A in TTBS con-
taining 1 mM CaCl2 and 1 mM MgCl2 (TTBSS) fol-
lowed by 1 h incubation with 0.5 μg/ml horseradish
peroxidase type I (Sigma) in TTBSS. For SNA and MAL
detection, membranes were incubated overnight in
TTBS with 0.5 or 5 μg/ml SNA or MAL lectin, respec-
tively. Membranes were further incubated for 1 h with
0.02 μg/ml streptavidin-peroxidase (Sigma). Detection
was performed with the Immobilon Western chemilumi-
nescent HRP substrate (ECL) (Millipore).
Immunoblot was performed as previously described
[22]. The following antibodies were used: mouse anti-
CD9 (1:5000) and mouse anti-L1 (L1-11A) (1:3).
Glycosidase treatment
Hydrolysis of a2,3- and a2,6-linked NeuAc from total
protein cellular extracts and exosomes was carried out
overnight at 37°C by the addition of 15 mU neuraminidase
from Vibrio cholerae or from Arthrobacter urefaciens
(Roche) in 50 mM sodium acetate pH 5.5 containing 4
mM CaCl2, and 50 mM sodium acetate pH 5.0, respec-
tively. For specific hydrolysis of a2,3-linked NeuAc, 9 U
neuraminidase from Streptococcus pneumoniae (Prozyme,
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Uptake of SKOV3 exosomes by SKOV3 cells
SKOV3 exosomes were labeled with carboxyfluoresceine
diacetate succinimidyl-ester (CFSE) (Invitrogen) as pre-
viously described [12]. Briefly, exosomes (20 μg) col-
lected after a 100,000 × g ultracentrifugation were
incubated with 7.5 μM CFSE for 30 min at 37°C in a
final volume of 200 μl PBS containing 0.5% BSA.
Labeled exosomes (Exos-CFSE) were 65-fold diluted
with DMEM supplemented with 10% vesicles-free fetal
calf serum and pelleted by ultracentrifugation for 16 h
at 10,0000 × g, 12°C. Exos-CFSE were resuspended in
DMEM and incubated with SKOV3 cells at 37 or 4°C.
When indicated Exos-CFSE or cells were treated for 30
min with 100 μg/ml proteinase K, or for 2 h with 15 mU
neuraminidase from V. cholerae or from A. urefaciens
(Roche), before uptake. SKOV3 cells were also incubated,
30 min prior to and during uptake, with the inhibitors
10 μg/ml chlorpromazine, 5 μg/ml cytochalasin D,
50 μM 5-ethyl-N-isopropyl amiloride (EIPA) or
2% methyl-beta-cyclodextrin, or with 150 mM of the
monosaccharides D-glucose, D-galactose, a-L-fucose,
a-D-mannose, D-N-acetylglucosamine, and the dis-
accharide b-lactose (Sigma).
Uptake assays were always performed in the presence
of the compounds and analyzed after 2 or 4 h by immu-
nofluorescence microscopy or flow cytometry.
Immunofluorescence microscopy
Immunofluorescence microscopy was done as previously
described [22]. Primary antibodies were: mouse IgG
anti-alpha-tubulin DM1A (1:2000) (Sigma), mouse IgG
anti-EEA1 (1:100) (BD Biosciences), mouse IgG anti-
LAMP1 H4A3 (1:100) (BD Biosciences) and mouse IgG
anti-caveolin-1 (1:50) (Santa Cruz). Secondary antibody
was donkey anti-mouse IgG AlexaFluor 594 (1:500)
(Molecular Probes).
Images were acquired on a Leica DMRB microscope
using a DFC340FX camera coupled to the microscope,
and Leica application suite V3.3.0 software. For colocali-
zation, images were acquired on a confocal SP5 micro-
scope. Each picture was acquired with laser intensities
and amplifier gains adjusted to avoid pixel saturation.
Each fluorophore used was excited independently and
sequential detection was performed. Each picture con-
sisted of a z-series of 20 images of 1024-1024 pixel reso-
lution with a pinhole of 1.0 airy unit. Colocalization
analysis was performed using the open source Image J
version 1.38 http://rsb.info.nih.gov/ij/.
Flow cytometry
SKOV3 cells incubated with Exos-CFSE for 4 h at 37 or
4°C were washed with PBS, detached using trypsin and
resuspended in PBS with 2% fetal calf serum (Gibco).
Flow cytometry analysis was performed on a Cyflow ML
cytometer (Partec) using Flowmax software 2.56 (Par-
tec). Gate was set on living cells based on forward/side
scatter properties and a minimum of 10
3 events within
the gated live population were collected per sample.
Exos-CFSE uptake by SKOV3 cells was measured by the
shift in peak fluorescence intensity of CFSE, calculated
by the geometric mean of the population. SKOV3 cells
with no Exos-CFSE uptake (unlabelled) were used
as controls for cell autofluorescence. Results were
expressed as means ± S.D. and comparison between two
means was performed by Student t test. A P value lower
than 0.05 was considered significant.
Results
Uptake of SKOV3 exosomes by SKOV3 cells
Since it has been shown that SKOV3 exosomes can be
internalized by NK cells [12] here we have investigated
if they are internalized by the cell line from where they
originated. With that purpose exosomes produced in the
absence of fetal bovine serum and collected at 100,000 ×
g were labeled with CFSE (Exos-CFSE) and incubated
with SKOV3 cells. CFSE is a membrane permeable non-
fluorescent compound that becomes fluorescent after
cleavage of its acetate groups by intracellular esterases
[23]. A punctuated green fluorescent pattern corre-
sponding to Exos-CFSE interaction/internalization was
observed after 30 min and it increased up to 4 hours of
incubation (Figure 1A). To obtain a higher sensitivity
exosomes were also biotinylated and detected with
streptavidin Alexa-488, and the interaction was observed
already 0.5 min after incubation (data not shown). Colo-
calization studies by immunofluorescence confocal
microscopy of Exos-CFSE and alpha-tubulin, a microtu-
b u l em a r k e r ,s h o w e dt h a tE x o s - C F S Ew e r el o c a l i z e di n
the same z-stacks as microtubules, thus, confirming
their internalization (Figure 1B). Supporting this conclu-
sion was the observation that the exosomes were not
removed by acid wash of cells pre-exposed to Exos-
CFSE (data not shown).
Several endocytic mechanisms have been described to
mediate the entry of material into the cells [24]. Here, we
observed that a decrease in temperature from 37 to 4°C
caused a reduction of 80 ± 8% (n = 6) in the number of
labeled cells as well as a decrease of 77 ± 9% (n = 6) in
the uptake for the positively labeled cells, based on the
shift in fluorescence intensity corresponding to the geo-
metric mean of the population peaks (Figure 2A). These
results indicated that exosomes uptake was mediated by
endocytosis in an energy-dependent process. Exos-CFSE
were also found to partially colocalize with the endoso-
mal marker EEA1 (Figure 2B), thus showing the partici-
pation of clathrin-mediated endocytosis in exosome
uptake. This conclusion was further supported by uptake
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chlorpromazine, which blocks clathrin-mediated endocy-
tosis [25]. Colocalization with the lysosomal marker
LAMP1 (Figure 2B) indicated that at least a part of the
exosomes were targeted to the lysosome.
In addition other inhibitors have been tested. First,
cells incubated with 5 μg/ml cytochalasin D, which is
known to inhibit actin polymerization and consequently
inhibit phagocytosis [26] as well as other endocytic
pathways [27] showed an uptake reduction of 32 ± 7%
(n = 4) (Figure 2C). EIPA at 50 μM, which is known to
block macropinocytosis [28], caused an uptake reduction
of 36 ± 13% (n = 5) (Figure 2C), thus suggesting that
exosomes were internalized via macropinocytosis.
Methyl-beta-cyclodextrin, that is used to deplete choles-
terol from cellular membranes [29], decreased Exos-
CFSE uptake (44 ± 8%, n = 5) (Figure 2C). However,
there was no colocalization with caveolin-1 (Figure 2B),
which is a marker of caveolae that are enriched in
cholesterol rich domains. These results indicated that
exosome uptake could occur via a cholesterol associated
pathway independent of caveolae or that methyl-beta-
cyclodextrin affected exosomes membrane integrity,
thus decreasing uptake efficiency.
Exos-CFSE did not colocalize with the Golgi marker
GM130, the trans-Golgi network marker TGN46 or the
endoplasmic reticulum marker calnexin (data not
shown).
Proteins are required for exosomes uptake
The recognition between exosomes and the target cell
has been reported to involve proteins present at the cell
surface of both exosomes and target cells [11,14]. Here,
Exos-CFSE or SKOV3 cells were digested with protei-
nase K, a broad specificity protease, and uptake effi-
ciency was analyzed by flow cytometry analysis. Uptake
levels of digested Exos-CFSE were found to be lower
( 4 5±1 2 % ,n=6 )t h a nE x o s - C F S Ew i t h o u tt r e a t m e n t
(Figure 3A). As control, fluorescence of Exos-CFSE was
not affected by proteinase K treatment (data not
s h o w n ) .F u r t h e r m o r e ,ad e c r e a s eo f3 2±8 %( n=6 )i n
uptake was observed in SKOV3 cells treated with protei-
nase K (Figure 3B). Therefore, proteins present in exo-
somes and also in SKOV3 cells are required, at least in
part, for internalization by target cells.
Enrichment of specific glycoproteins in exosomes and
relevance in uptake
Glycan-lectin interactions have been suggested to play a
role in the uptake of exosomes by target cells [19,20],
therefore, we have investigated if glycans would play a
role in exosome uptake by SKOV3 cells.
First, glycoproteins of cellular extracts and secreted vesi-
cles from SKOV3 cells were detected with the lectins con-
canavalin A (Con A; binds a-mannosyl containing-
branched glycans predominantly of the high-mannose fol-
lowed by hybrid- and biantennary complex type structures
to a lower extent) [30], Sambucus nigra lectin (SNA;
recognizes NeuAca2,6Gal/GalNAc) and Maackia amur-
ensis lectin (MAL; binds NeuAca2,3Galb1,4GlcNAc/Glc)
[31]. The profile from exosomes was distinct from that of
cellular extracts with the three lectins (Figure 4A). Detec-
tion with SNA and MAL was almost totally abolished after
digestion with V. Cholerae and A. urefaciens neuramini-
dases (cleave terminal a2,3- and a2,6-linked NeuAc),
whereas only MAL binding was abolished after S. pneumo-
niae (cleaves only a2,3-linked NeuAc) digestion (Figure
4B), thus confirming that SNA and MAL binding to
secreted vesicles glycoproteins was specific. The sialic acid
was not present in sialylated Lewis epitopes, since there
was no detection with anti-sialyl-Lewis
a or anti- sialyl-
Lewis
x antibodies (data not shown).
Figure 1 Uptake of SKOV3 exosomes by SKOV3 cells. (A) SKOV3 cells were incubated with Exos-CFSE (20 μg protein; green) for 4 h and were
visualized in bright-field merged with fluorescence microscopy. Scale bar = 20 μm. (B) Detection of Exos-CFSE (green) and alpha-tubulin (red) by
confocal immunofluorescence microscopy. Scale bar = 10 μm.
Escrevente et al. BMC Cancer 2011, 11:108
http://www.biomedcentral.com/1471-2407/11/108
Page 4 of 10Figure 2 Path of internalization of exosomes in SKOV3 cells. (A) Exos-CFSE (20 μg protein; green) were incubated with SKOV3 cells at 37 or
4°C and uptake was monitored by flow cytometry analysis of cell fluorescence intensity. Solid and dashed lines represent Exos-CFSE uptake at
37 and 4°C, respectively. (B) Colocalization of Exos-CFSE (20 μg protein; green) with EEA1 (red), LAMP1 (red) and caveolin-1 (red). Secondary
antibody was donkey anti-mouse IgG AlexaFluor 594. Colocalization is indicated in yellow. Images in the left bottom represent 4 ×
magnifications of selected areas. Scale bars = 10 μm. (C) Effect of chlorpromazine, cytochalasin D, EIPA and methyl-beta-cyclodextrin (30 min
pre-incubation) on Exos-CFSE uptake (4, 4, 4 and 2 h, respectively) monitored by flow cytometry analysis (dashed lines). Controls consist of
SKOV3 cells with no treatment for chlorpromazine and methyl-beta-cyclodextrin, or treated with DMSO for cytochalasin D and EIPA (solid lines).
Unlabelled SKOV3 cells (grey) were used as control for cell autofluorescence. The results shown are representative of three independent
experiments.
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and apoptotic vesicles, which can be fractionated by
using a sucrose gradient, as previously described [21,22].
CD9 is a tetraspanin protein that has been used as exo-
some marker [32,33]. After sucrose gradient separation
of the secreted vesicles all the SNA and MAL binding
was found in the exosome-containing fractions (frac-
tions 2-5) and not in the apoptotic blebs (fractions 8-11)
(Figure 4C).
Specific patterns of protein glycosylation were also
found for exosomes from two other human cell lines,
embryonic kidney HEK293 and neuroglioma H4 cells
(Figure 5).
To investigate a possible role for glycosylation in exo-
some uptake Exos-CFSE were desialylated with V. cho-
lerae and A. urefaciaens sialidases and exosomes uptake
was monitored by immunofluorescence microscopy and
flow cytometry analysis of cell fluorescence intensity.
Uptake efficiency of exosomes after neuraminidase treat-
ment was slightly increased (16 ± 14%, n = 6) when
compared with exosomes incubated with neuraminidase
buffer (Figure 6A), however, the observed increase was
not statistically significant using the Student t test (P =
0.0764). In addition, increases in the uptake of exosomes
incubated with neuraminidase (38 ± 13%, n = 6) or
neuraminidase buffer (23 ± 14%, n = 6) were detected
when compared with Exos-CFSE without treatment
(Figure 6A).
T h eu p t a k ea s s a yw a sa l s op e r f o r m e di nt h ep r e s e n c e
of 150 mM of the monosaccharides D-glucose (control),
D-galactose, a-L-fucose, a-D-mannose and D-N-acetyl-
glucosamine, and the disaccharide b-lactose. Decreases
of 23 ± 7%, 24 ± 14%, 25 ± 16%, 27 ± 8%, 19 ± 15%
and 20 ± 8% (n = 6), respectively, in the uptake of Exos-
CFSE in comparison with control without sugar were
observed. The incubation with a-D-mannose led to a
higher decrease in uptake relatively to the control sugar
D-glucose, however the difference was not statistically
significant (Figure 6B).
Discussion
Exosomes are small membrane vesicles that are secreted
by several cell types, including tumors and they have
been found in biological fluids. They contain several
membrane and cytoplasmic proteins and, in cancer, they
play a role in cell migration and metastases. They may
also transfer proteins associated with deregulated signal-
ling pathways in cancer [34,35], therefore, contributing to
the propagation of transformed phenotype. Furthermore,
the exosomes may transfer mRNA and miRNA [36].
In the present work, we have found that the SKOV3
ovarian carcinoma cell line internalizes exosomes
derived from the same cells in an energy-dependent
process, via various endocytic pathways: colocalization
studies with organelle markers and incubation with
inhibitors have shown that the endocytosis pathway
dependent on clathrin, macropinocytosis and a choles-
terol associated pathway independent of caveolae were
associated with the uptake. Evidence from the litera-
ture showed that in dendritic cells exosome uptake
was also inhibited at 4°C and with cytochalasin D, and
was further trafficked to the late endosomes/lysosomes
[14]. In phagocytic cells, more specifically macro-
phages, internalization was also dependent on the actin
cytoskeleton but not on pathways involving caveolae,
macropinocytosis or clathrin-coated vesicles [15]. In
the PC12 cell line exosomes uptake was also found to
occur via the endocytic pathway [27]. After internaliza-
tion, exosomes could fuse with the endosomal mem-
brane and deliver their content to the cytoplasm of the
target cell. For SKOV3 cells such process could take
place over a long period of time since internalized exo-
somes were detected in the cells for at least 20 h (data
not shown).
Figure 3 Effect of proteinase K treatment in SKOV3 exosomes uptake. (A) Exos-CFSE (20 μg protein; green) or (B) SKOV3 cells were treated
with 100 μg/ml proteinase K for 30 min. Uptake was determined after 4 h of incubation by flow cytometry analysis and compared with uptake
of Exos-CFSE with no treatment (solid lines). Unlabelled SKOV3 cells (grey) were used as control for cell autofluorescence. Dashed lines represent
Exos-CFSE uptake after proteinase K digestion. The results shown are representative of three independent experiments performed in duplicate.
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involve several molecules, proteins [16] and lipids [12]
have already been indicated as involved in this process.
In this work, the impairment observed for vesicles or
cells treated with proteinaseKi n d i c a t e dt h a tp r o t e i n s
from the extracellular surface from both target cells and
exosomes are required for internalization. Further stu-
dies to identify which proteins play an important role in
the recognition are required.
H e r ew ea l s of o u n dt h a te x o s o m e sf r o mS K O V 3c e l l s
are particularly enriched in specific glycoproteins with
high-mannose or NeuAca2,3/6-containing structures. In
this context, other authors, using lectin arrays, have also
observed the enrichment in T-cells secreted microvesi-
cles of high-mannose and sialic acid-containing struc-
tures in comparison with cell membranes [18].
Furthermore, an enrichment of more extensively glyco-
sylated forms of PrPc has been found in the exosomes
in comparison with cell lysates [37].
Removal of NeuAc from the exosomes with neuramini-
dase led to an increase in the uptake, but non-significant.
The removal of NeuAc decreased the negative charge at
the exosome surface exposing galactose or N-acetylgalac-
tosamine residues. This could lead to physico-chemical
Figure 4 Western blot and lectin detection of glycoproteins from SKOV3 cellular extracts (Ext) and secreted vesicles (Ves). (A) Con A,
SNA and MAL lectin detection in SKOV3 cellular extract and vesicles. Three μg total protein were applied per lane. As positive controls, 200 ng
ribonuclease B (RNase B) [41], human plasma transferrin (TFR) [42] and erythropoietin (EPOBRP) [43] were used. (B) SNA and MAL lectin analysis of
desialylated SKOV3 cellular extracts and vesicles. Total proteins (3 μg) were digested with neuraminidases from V. cholerae (Vb), A. urefaciens (Au)
and S. pneumonia (Sp). Input consisted of cellular extracts and exosomes without treatment. As loading control L1 was detected. (C) Vesicles
from 1.5 × 10
7 SKOV3 cells were fractionated in a sucrose gradient. Cellular extracts (Ext), secreted vesicles from 100,000 × g pellet (Ves), pooled
fractions 2-5 (F2-5) (3 μg total protein), 20% of F1, F6-7, F8-11 and F12 were analysed. As positive control for exosomes, CD9 was detected.
Detection was performed using the chemiluminescent method.
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carbohydrate binding proteins at the surface of the cells
that would mediate the binding.
The monosaccharides D-galactose, a-L-fucose, a-D-
mannose, D-N-acetylglucosamine and the disaccharide
b-lactose reduced exosomes uptake to a comparable
extent as the control D-glucose probably due to
increased osmotic pressure that is known to reduce
endocytosis [38]. Therefore, these sugars do not play a
major role in exosome interaction and uptake in SKOV3
cells. This result is different from that found in dendritic
cells where exosome uptake was specifically inhibited by
mannose and N-acetylglucosamine, the interaction being
at least in part mediated by a C-type lectin [19], or in
macrophages where lactose diminished exosome uptake
probably through its action on galectin-5 that mediated
the process [20].
Here, certain glycoproteins were specifically detected
in exosomes and may constitute markers. It will be
interesting to investigate if those glycoproteins are selec-
tively sorted to the exosomes or if only certain glyco-
forms from the same protein are sorted into the
exosomes. It can be admitted that glycans by themselves
m a yb ei m p o r t a n tf o rg l y c o protein sorting into exo-
somes. Since protein oligomerization is known to pro-
mote sorting into exosomes independently of the
ESCRT machinery and ubiquitination [16], the glycans
could mediate oligomerization via interaction with lec-
tins as previously described for the transferrin receptor
in reticulocytes [39]. Moreover, glycans may interact
with galectins at the cell surface, which may lead to
their enrichment in membrane lipid domains as pre-
viously described [40]. Considering that lipid microdo-
m a i n sp l a yar o l eo ne x o s o m e sb i o g e n e s i s[ 1 6 ] ,g l y c a n s
could in that case also have a role on sorting to exo-
somes. Further studies are required to clarify this
matter.
Exosomes contain cell surface cancer antigens, which
confers them the potential for therapeutic approaches in
cancer vaccination. Our observation that they are parti-
cularly enriched in glycan epitopes urges the need to
Figure 5 Con A, SNA and MAL lectin detection of glycoproteins from HEK293 and H4 cellular extract (Ext) and secreted vesicles (Ves).
For the analysis, 3 μg of total protein were applied per lane. Detection was performed using the chemiluminescent method.
Figure 6 Effects of neuraminidase and sugars on SKOV3
exosomes uptake. (A) Exos-CFSE (20 μg protein) were incubated
with 15 mU V. cholerae neuraminidase or corresponding buffer for
2 h before Exos-CFSE uptake. (B) Effect of 150 mM D-glucose (Glc),
a-L-fucose (Fuc), a-D-mannose (Man), b-lactose (Lac), D-galactose
(Gal) and D-N-acetylglucosamine (GlcNAc) (30 min pre-incubation)
on Exos-CFSE uptake (4 h) monitored by flow cytometry analysis.
Uptake efficiency was calculated relatively to the uptake without
treatment, considered as 100%. Results are displayed in relative
percentages ± S.D. The results shown are representative of three
independent experiments performed in duplicate.
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one of the major changes that occur in cancer is in cell
surface glycosylation, which has been largely used as
biomarker. The knowledge of exosomes glycosylation
with the possibility for its modulation will open new
perspectives in cancer vaccination.
Conclusions
Exosomes secreted by the ovarian cancer SKOV3 cell
line are internalized by the same cells, and internaliza-
tion is energy-dependent and it occurs via various endo-
cytic pathways. Moreover, the interaction requires
proteins from the cells and the exosomes. On the other
hand, the exosomes were found to be enriched in speci-
fic mannose- and sialic acid-containing glycoproteins
that could constitute exosome markers. Furthermore,
sialic acid removal caused a small though non-signifi-
cant increase in uptake.
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